It can reveal plaque in arteries, offering a more precise estimate of a person’s risk of heart disease. Yet the test remains ...

Coronary Artery Disease significantly impacts women in India, often remaining underdiagnosed despite high mortality rates. A ...

Reduced left ventricular ejection fraction and an increased extent of obstructive coronary artery disease signal an elevated ...

The Acute Coronary Syndrome market report provides a global historical and forecasted market covering drug outreach in 7MM.

Background Postoperative cerebral infarction following coronary artery bypass grafting (CABG) for multivessel coronary artery ...

In TODAY.com's Expert Tip of the Day, a cardiologist reveals a common early symptom in patients with coronary artery disease.

New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...

Medcare Hospital Al Safa introduces new AI diagnostic technologies to detect & predict onset of cardio related diseases ...

Advanced Provides Clarity in 3D Heartflow Plaque Analysis is the only FDA-cleared, AI-powered plaque quantification tool with a reported 95% agreement with the gold standard, IVUS, using blinded core ...

Dr. Peder Myhre: Welcome listeners to this week's issue of Circulation on the Run, the week of September 23. I am Dr. Peder ...

All implanted CTEVs remained patent through six months, demonstrated adaptive remodeling, and recellularized with host coronary artery cells – DURHAM, N.C., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Humacyte ...

The Food and Drug Administration cleared Heartflow's technology to quantify coronary plaque and the platform is now available, the company said.